Tris Pharma Announces FDA Approval of Dyanavel XR (amphetamine) Once-Daily Extended-Release Oral Tablets, CII, for ADHD

In a clinical study in adults, Dyanavel XR tablets demonstrated bioequivalence to Dyanavel XR (amphetamine) extended-release oral suspension. ADHD patients taking Dyanavel XR oral suspension can conveniently switch to the same dose of Dyanavel XR...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news